Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Jones Lang LaSalle Inc (JLL) Price & Performance

ADMA Biologics IncTrade
Jones Lang LaSalle IncTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Jones Lang LaSalle Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Jones Lang LaSalle Inc trades at $361.02 (market cap $16.72B). The key difference: Jones Lang LaSalle Inc is far larger — about 7.5× ADMA Biologics Inc's market cap, and Jones Lang LaSalle Inc is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.

ADMAJLL
Market Cap
$2.22B$16.72B
Sector
HealthReal Estate
52-Week High
$20.38$373.24
52-Week Low
$7.60$280.16
Enterprise Value
$2.29B$19.48B

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Jones Lang LaSalle Inc

Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $70 billion for clients across diverse public and private real estate strategies.

Read more on JLL